Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-Methyl-4-propylpiperazine Bosutinib

1-Methyl-4-propylpiperazine Bosutinib is listed in the pharmaceutical impurity collection. Its represented structure has formula C34H45Cl2N7O3 and a calculated molecular weight of 670.69 g/mol.

2D chemical structure

O N N N N N O N N O C l C l

Chemical identity

Catalog name
1-Methyl-4-propylpiperazine Bosutinib
Common name
1-Methyl-4-propylpiperazine Bosutinib
Chemical name
4-[2,4-dichloro-5-methoxy-N-[3-(4-methylpiperazin-1-yl)propyl]anilino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
CAS
Not available
SMILES
COc1cc(N(CCCN2CCN(C)CC2)c2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
InChI
InChI=1S/C34H45Cl2N7O3/c1-39-10-14-41(15-11-39)7-5-9-43(30-22-31(44-3)28(36)20-27(30)35)34-25(23-37)24-38-29-21-33(32(45-4)19-26(29)34)46-18-6-8-42-16-12-40(2)13-17-42/h19-22,24H,5-18H2,1-4H3
InChIKey
KREAHQAQNLTGOU-UHFFFAOYSA-N

Record ID: Aa1e19afe92b6

Computed properties

C34H45Cl2N7O3 Molecular formula
670.686 g/molMolecular weight
669.2961 DaMonoisotopic exact mass
80.57 ŲTopological polar surface area
5.2224 Calculated LogP (Wildman–Crippen)
185.633 cm³/molMolar refractivity (Wildman–Crippen)
10 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 4 8 12 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O 0 10 20 30 40 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight670.68694.31
Calculated LogP (Wildman–Crippen)5.222491.14
Topological polar surface area80.5758.28
Hydrogen-bond acceptors1093.21
Hydrogen-bond donors011.28
Rotatable bonds (strict)1394.96

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC34H45Cl2N7O3dimensionless
Molecular weight670.686g/mol
Monoisotopic exact mass669.2961Da
Topological polar surface area80.57Ų
Calculated LogP (Wildman–Crippen)5.2224dimensionless
Molar refractivity (Wildman–Crippen)185.633cm³/mol
Hydrogen-bond acceptors10count
Hydrogen-bond donors0count
Rotatable bonds (strict)13count
Heavy atoms46count
Heteroatoms12count
Rings5count
Aromatic rings3count
Aliphatic rings2count
Saturated rings2count
Aromatic heterocycles1count
Aliphatic heterocycles2count
Saturated heterocycles2count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.5294fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area282.451Ų
Valence electrons248count
Radical electrons0count
Bertz complexity1,519.0885index
Balaban J1.4504index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-Methyl-4-propylpiperazine Bosutinib

Qualification and safety assessment of 1-Methyl-4-propylpiperazine Bosutinib

Explore toxicological qualification of 1-Methyl-4-propylpiperazine Bosutinib and ICH M7 mutagenic impurity assessment of 1-Methyl-4-propylpiperazine Bosutinib for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-Methyl-4-propylpiperazine Bosutinib and acceptable intake and limit justification for 1-Methyl-4-propylpiperazine Bosutinib. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-Methyl-4-propylpiperazine Bosutinib

Explore Altox services and software through the Altox Pharma-Hub.